Publications

June 29, 2021

The TIGIT Pathway, PVRIG, a Novel Pathway Member, Targets for Cancer Immunotherapy: A Deep Dive

Eran Ophir, VP Research and Drug Discover June 2021.

April 13, 2021

Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis

Zoya Alteber, Maya F Kotturi, Sarah Whelan, et al.

December 10, 2019

Activation of Human NK Cells Modulates Expression of the Inhibitory Reception PVRIG

Jessica Li, el al, The Australian and New Zealand Society for Immunology (ASI) Annual Meeting

Scroll to Top